A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - Rationale and design [ISRCTN55725285]

Cornel Pater, Deepak Bhatnagar, Jean Pascal Berrou, Joachim Luszick, Katrin Beckmann

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Hypertension and diabetes mellitus are closely interrelated and coexist in as many as two-thirds of patients with type 2 diabetes. The consequent risk of such an association is an accelerated development of atherosclerotic cardiovascular disease and nephropathy complications. In choosing an antihypertensive agent, effectiveness needs to be accompanied by favourable metabolic, cardioprotective, and nephroprotective properties. Given the multifactorial nature of hypertension, the approach that has gained widespread agreement is treatment with more than one agent. Agents with different mechanisms of action increase antihypertensive efficacy because of synergistic impacts on the cardiovascular system. Combination therapy allows the use of lower doses of each antihypertensive agent which accounts for the excellent tolerability of combination products. The aim of the present study is to quantify the efficacy of combination therapy of Eprosartan 600 mg respectively Ramipril 5 mg with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with essential hypertension and associated diabetes mellitus type 2. The use of monotherapy (Eprosartan or Ramipril) followed by addition of low-dose Hydrochlorothiazide as second agent and of Moxonidine as a third agent will be individualized to the severity of hypertension in the particular patient and to his/her degree of response to current treatment. © 2004 Pater et al; licensee BioMed Central Ltd.
    Original languageEnglish
    Article number9
    JournalCurrent Controlled Trials in Cardiovascular Medicine
    Volume5
    DOIs
    Publication statusPublished - 1 Oct 2004

    Fingerprint

    Dive into the research topics of 'A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - Rationale and design [ISRCTN55725285]'. Together they form a unique fingerprint.

    Cite this